Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-Analysis
December 2025
in “
International Neurourology Journal
”
This study evaluated the potential dementia risk associated with alpha-blockers and 5-alpha reductase inhibitors (5ARIs) in patients with benign prostatic hyperplasia (BPH) by analyzing data from 5 multicenter studies involving 3,650,434 patients. The results indicated no significant association between these medications and an increased risk of dementia. However, 5ARIs showed a relatively higher probability of dementia risk compared to other treatments. The findings suggest that these medications can be prescribed without significant concern for dementia risk, but further large-scale research is recommended to confirm these results.